- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05866718
Can Applying the Science of Habit Formation to Contemplative Practice Improve Outcomes
Can Applying the Science of Habit Formation to Contemplative Practice Improve Outcomes? A Randomized Controlled Trial of a Single-Session Habit Formation Intervention for Self-Compassionate Touch
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Specific Aim 1: Evaluate whether SCT+HABITS shows more practice frequency and practice automaticity from baseline to 3-month, and to 6-month follow-up compared to the SCT. Hypothesis 1. The SCT+HABITS group will show greater increases in practice frequency and practice automaticity than SCT from baseline to 3-month, and to 6-month follow-up.
Specific Aim 2: Determine whether SCT+HABITS, relative to SCT, will experience increased self-compassion and self-compassion automaticity, and reduced stress and psychopathology. Hypothesis 2. SCT+HABITS will promote greater increases in self-compassion and self-compassion automaticity, and greater reductions in stress and psychopathology from baseline to 3-month, to 6-month follow-up.
Specific Aim 3: Assess whether greater baseline to 3-month follow-up increases in practice automaticity mediate the association between SCT+HABITS and baseline to 6-month follow-up increases in (a) self-compassion and (b) self-compassion automaticity, as well as reductions in (c) stress and (d) psychopathology. Hypothesis 3. Greater baseline to 3-month follow-up increases in practice automaticity will mediate the association between the SCT+HABITS group and baseline to 6-month follow-up increases in (a) self-compassion and (b) self-compassion automaticity, as well as reductions in (c) stress and (d) psychopathology.
Exploratory Aim: Evaluate the barriers, facilitators, and acceptability of SCT+HABITS and SCT alone. This aim will be addressed via qualitative analyses to characterize barriers and facilitators to habit formation, and the proportion of participants in each condition (SCT+HABITS and SCT alone) who noted each type of barrier and facilitator. Participants will self-report on acceptability and feasibility via questionnaire. Then, the investigators will examine whether SCT+HABITS and SCT alone will meet or exceed the established criteria for acceptability and feasibility.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Berkeley, California, United States, 94720-1650
- University of California at Berkeley
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 18 years of age or older.
- English language proficiency.
- Able and willing to give informed consent.
- Resides in the United States of America
Exclusion Criteria:
- Does not have email address or access to email.
- Does not personally own a smartphone device
- Not able/willing to participate in and/or complete the baseline assessments
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Self-Compassionate Touch Intervention Alone
All participants will receive the self-compassion intervention after completing their baseline assessment, which will contain the same instructions used in the initial study (see NCT05199779).
|
Participants will be taught the micropractice (<20-second/day personal practice) via video recording.
|
Experimental: Self-Compassionate Touch Intervention Plus Habit Formation Tools
SCT+HABITS participants will receive the abovementioned procedures, and will also receive evidence-based tools for forming habits.
|
Participants will be taught the micropractice (<20-second/day personal practice) via video recording.
Participants will receive evidence-based tools for promoting habit-formation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Practice Frequency
Time Frame: Change from baseline to 3-month follow-up, and to 6-month followup
|
Number of times practiced self-compassion exercise per week since last assessment.
1 item.
Higher frequency indicates a better outcome.
|
Change from baseline to 3-month follow-up, and to 6-month followup
|
Practice Automaticity (Practice Self-Report Behavioral Automaticity Index [SRBAI])
Time Frame: Change from baseline to 3-month follow-up, and to 6-month follow-up.
|
4 items, 1-9 scale.
Higher scores indicate a better outcome.
|
Change from baseline to 3-month follow-up, and to 6-month follow-up.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Self-Compassion (Sussex-Oxford Compassion for the Self Scale [SOCS-S])
Time Frame: Change from baseline to 3-month follow-up, and to 6-month followup
|
20-items, 5-point response scale.
Scores can range from 20 to 100 (Higher score means higher compassion for self).
Sub-scale items included.
|
Change from baseline to 3-month follow-up, and to 6-month followup
|
Psychopathology (DSM-5 Cross-Cutting Measure [DSM-XC])
Time Frame: Change from baseline to 3-month follow-up, and to 6-month followup
|
22 items (suicidality item Q11 removed).
5-point scale (0=none or not at all; 1=slight or rare, less than a day or two; 2=mild or several days; 3=moderate or more than half the days; and 4=severe or nearly every day).
|
Change from baseline to 3-month follow-up, and to 6-month followup
|
Self-Compassion Automaticity (Self-Compassion Self-Report Behavioral Automaticity Index [SRBAI])
Time Frame: Change from baseline to 3-month follow-up, and to 6-month followup.
|
20 items.
1-9 scale.
Higher scores indicate a better outcome.
|
Change from baseline to 3-month follow-up, and to 6-month followup.
|
Perceived Stress (Perceived-Stress Scale [PSS-10])
Time Frame: Change from baseline to 3-month follow-up, and to 6-month followup
|
10 items, 5 point response scale (from 0 = Never to 4 = Very Often). Lower scores indicate a better outcome. Scoring: Reverse score (e.g., 0 = 4, 1 = 3, 2 = 2, 3 = 1 & 4 = 0) items 4, 5, 7, & 8 and then summing across all scale items. |
Change from baseline to 3-month follow-up, and to 6-month followup
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Acceptability and Feasibility (Program Feedback Scale [PFS])
Time Frame: Assessed at 6-month followup
|
7 Items.
5-point scale (1="really disagree"; 5="totally agree")
|
Assessed at 6-month followup
|
Barriers and Facilitators
Time Frame: Assessed at 6-month followup
|
The investigators will explore first-person experience of using the practice by asking open-ended free-response questions.
The investigators will develop a coding system of the barriers and facilitators to forming the habit of practicing SCT daily.
|
Assessed at 6-month followup
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Eli S Susman, University of California, Berkeley
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2021-12-14924-2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Psychopathology
-
Institut pour la Pratique et l'Innovation en PSYchologie...BPIfranceRecruiting
-
University of California, BerkeleyCompletedTransdiagnostic PsychopathologyUnited States
-
Reproductive Medicine Associates of New JerseyWithdrawnAttitudes | Psychopathology | ReactionsUnited States
-
University of Notre DameRecruitingAdolescent | Parent-Child Relations | Violence | PsychopathologyUnited States
-
University of Turin, ItalyCompletedGeneral Psychopathology | Heavy MHS Use | Working Alliance
-
Boston Children's HospitalTulane University; Harvard University; University of Maryland, College Park; Inter-American... and other collaboratorsRecruitingPsychopathology | Brain Function | Socioemotional Development | Cognitive Ability | Behavioral and Neural Patterns of AttentionBrazil
-
Eunice Kennedy Shriver National Institute of Child...National Institute of Mental Health (NIMH)CompletedPsychopathologyUnited States
-
Universidad de GranadaCompleted
-
Tulane UniversityNational Institute of Mental Health (NIMH)Active, not recruiting
-
UMC UtrechtErasmus Medical Center; Academisch Medisch Centrum - Universiteit van Amsterdam... and other collaboratorsCompletedPsychopathology | Ecstasy (Drug) | N-Methyl-3,4-MethylenedioxymethamphetamineNetherlands
Clinical Trials on Self-Compassionate Touch Intervention
-
University of WaterlooSt. Joseph's Healthcare HamiltonEnrolling by invitationAnorexia Nervosa | Binge-Eating Disorder | Bulimia Nervosa | Compassion | Eating DisordersCanada
-
University of WaterlooCompletedThe Effects of Expressive Writing and Compassionate Letter Writing on Emotional Distress IntoleranceDistress IntoleranceCanada
-
University of Texas at AustinCompleted
-
University of SurreyCompletedCompassion | Perfectionism | Resilience | Rumination | Self-CriticismUnited Kingdom
-
Massachusetts General HospitalNational Institute on Aging (NIA); University of California, San FranciscoRecruitingQuality of Life | Caregiver Stress | Alzheimer's Disease and Related DementiasUnited States
-
Allen A. Greiner, MD, MPHNational Institutes of Health (NIH)CompletedColorectal CancerUnited States
-
Wroclaw University of Health and Sport SciencesUniversity of Silesia in Katowice; Jan Dlugosz University in CzestochowaCompleted
-
Ohio State UniversityNationwide Children's HospitalCompletedPrematurity | Stress ReactionUnited States
-
Hygeia Touch Inc.CompletedHuman Papillomavirus Infection | Vaginal Discharge | Self SamplingTaiwan